• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cabot Corporation Board Declares Dividend

    11/8/24 5:00:00 PM ET
    $CBT
    Major Chemicals
    Industrials
    Get the next $CBT alert in real time by email

    On Friday, November 8, 2024, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.43 per share on all outstanding shares of the Corporation's common stock. The dividend is payable on December 13, 2024, to stockholders of record at the close of business on November 29, 2024.

    About Cabot Corporation

    Cabot Corporation (NYSE:CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company's website at cabotcorp.com.

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot's business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241108092704/en/

    Get the next $CBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBT

    DatePrice TargetRatingAnalyst
    11/11/2024$105.00Neutral → Underweight
    JP Morgan
    4/18/2024Buy → Hold
    Deutsche Bank
    3/27/2024$104.00Buy
    Mizuho
    1/8/2024$90.00 → $87.00Buy → Neutral
    UBS
    6/6/2023$87.00 → $80.00Overweight → Neutral
    JP Morgan
    3/13/2023$94.00Outperform
    Credit Suisse
    11/16/2022$80.00 → $90.00Hold → Buy
    Deutsche Bank
    1/4/2022$75.00 → $70.00Buy
    UBS
    More analyst ratings

    $CBT
    SEC Filings

    See more
    • SEC Form 11-K filed by Cabot Corporation

      11-K - CABOT CORP (0000016040) (Filer)

      6/20/25 9:29:13 AM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

      8-K - CABOT CORP (0000016040) (Filer)

      6/3/25 10:15:33 AM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form 10-Q filed by Cabot Corporation

      10-Q - CABOT CORP (0000016040) (Filer)

      5/7/25 12:37:39 PM ET
      $CBT
      Major Chemicals
      Industrials